🔴 Opus Genetics is trading 5% down today with biotech weakness a possible backdrop

Opus Genetics is trading at $4.41, down 5.06%, with biotech-sector weakness a plausible backdrop.

• XBI fell 2.01% during the regular session, without a clear sector catalyst.
• Opus Genetics announced a presentation at the Chardan Annual Healthcare Conference on October 20; available coverage does not link it to the decline.
• No clear company-specific catalyst or reported trading-volume information was identified.